Cancer Q&A with HOA: Women's Cancer Prevention & Treatment

Hodgkin Lymphoma, AHOD2131

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma.

Lung, D926TC00001 “AZ Tropion-Lung12”

A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma Non-small Cell Lung Cancer who are ctDNA-positive or Have High-risk Pathological Features.

Lung, 61186372NSC2012 “Copernicus”

A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer.

Practical Meditation

Yin & Sound

Yin Yoga

Yin Yoga

Yin yoga is a slow-paced, passive style of yoga that focuses on stretching and hydrating the body's connective tissues, such as ligaments, tendons, and fascia, rather than muscles. 

Register at tinasyoga@gmail.com or call 315-247-3856.

November 2025

Sun Mon Tue Wed Thu Fri Sat
26
27
28
29
30
31
1
 
 
 
 
 
 
 
2
3
4
5
6
7
8
 
 
 
 
 
 
 
9
10
11
12
13
14
15
 
 
 
 
 
 
 
16
17
18
19
20
21
22
 
 
 
 
 
 
 
23
24
25
26
27
28
29
 
 
 
 
 
 
 
30
1
2
3
4
5
6
 
 
 
 
 
 
 
Submitted by admin on Fri, 2025-04-25 13:26

Zoledronic Acid

  • Brand name/Generic name: Zometa, Reclast/Zoledronic acid
  • How Administered at HOA: intravenous injection
  • Duration of Treatment: fifteen minutes
  • Frequency of Treatment: once a year
  • Conditions this Medication Treats: postmenopausal osteoporosis, Paget disease
  • Link for more Information: https://medlineplus.gov/druginfo/meds/a605023.html
Submitted by admin on Fri, 2025-04-25 13:26

Xolair

  • Brand name/Generic name: Xolair/omalizumab
  • How Administered at HOA: subcutaneous injection
  • Duration of Treatment: fast subcutaneous injection
  • Frequency of Treatment: every two to four weeks
  • Conditions this Medication Treats:
    • allergic asthma
    • IgE-mediated food allergy
    • chronic spontaneous urticaria (CUS)
    • chronic rhinosinusitis with nasal polyps (CRSwNP).

Pages